Reduction in Standard Cancer Screening in 2020 throughout the U.S.
Reduction in Standard Cancer Screening in 2020 throughout the U.S.
复制标题
DOI：
10.3390/cancers13235918
复制
发表时间：
2021-11-25
期刊：
影响因子：
5.2
通讯作者：
Arrington AK
中科院分区：
文献类型：
--
作者：
Dennis LK;Hsu CH;Arrington AK
COVID-19大流行对医疗保健（包括癌症筛查）产生重大影响。我们根据一项全国性调查，将2020年与2014-2019年美国癌症筛查百分比进行了比较。我们看到筛查性乳房X线检查、巴氏试验和乙状结肠镜检查/结肠镜检查的总体下降。在美洲印第安人/阿拉斯加原住民、西班牙裔和多种族参与者中，大多数下降幅度较高，但在非洲裔美国人/黑人中，巴氏试验的下降幅度也很高。随着疫情扩展至2021年，预计癌症筛查的减少将更高，从而增加癌症差异。癌症筛查是减轻癌症负担的重要途径。COVID-19大流行导致筛查延迟，有可能增加美国的癌症差异。分析了2014-2020年行为风险因素监测系统（BRFSS）调查的数据，以估计在过去12个月内报告癌症筛查的成年人的百分比，这些癌症筛查与美国预防服务工作组（USPSTF）在大流行之前对宫颈癌（21-65岁），乳腺癌（50-74岁）和结直肠癌（50-75岁）的建议一致。将2020年（4月至12月，不包括1月至3月）的癌症筛查百分比与2014年至2019年的筛查百分比进行比较，以开始研究COVID-19大流行的影响。2020年的筛查百分比比2014-2019年有所下降，包括几个服务不足的种族群体。在美洲印第安人/阿拉斯加原住民，西班牙裔和多种族参与者中，乳房X光检查和结肠镜检查或乙状结肠镜检查的减少率较高，但在西班牙裔，白人，亚洲人和非洲裔美国人/黑人中，巴氏试验的减少率也最高。40-49岁女性的乳房X光检查也有所减少。由于2020年的比较是保守的，预计2021年癌症筛查的下降幅度将更大，并可能大幅增加癌症差异。
The COVID-19 pandemic has had a significant impact on health care including cancer screening. We examined 2020 compared to the 2014–2019 cancer screening percentages in the United States (US) based on a national survey. We saw overall decreases in screening mammograms, pap tests, and sigmoidoscopy/colonoscopy. Most decreases were higher among American Indian/Alaskan Natives, Hispanics, and multiracial participants, but decreases in pap test were also high among African-Americans/Blacks. As the pandemic expanded into 2021, cancer screening reduction is expected to be higher, increasing cancer disparities. Cancer screening is an important way to reduce the burden of cancer. The COVID-19 pandemic created delays in screening with the potential to increase cancer disparities in the United States (U.S.). Data from the 2014–2020 Behavioral Risk Factor Surveillance System (BRFSS) survey were analyzed to estimate the percentages of adults who reported cancer screening in the last 12 months consistent with the U.S. Preventive Services Task Force (USPSTF) recommendation for cervical (ages 21–65), breast (ages 50–74), and colorectal cancer (ages 50–75) prior to the pandemic. Cancer screening percentages for 2020 (April–December excluding January–March) were compared to screening percentages for 2014–2019 to begin to look at the impact of the COVID-19 pandemic. Screening percentages for 2020 were decreased from those for 2014–2019 including several underserved racial groups. Decreases in mammography and colonoscopy or sigmoidoscopy were higher among American Indian/Alaskan Natives, Hispanics, and multiracial participants, but decreases in pap test were also highest among Hispanics, Whites, Asians, and African-Americans/Blacks. Decreases in mammograms among women ages 40–49 were also seen. As the 2020 comparison is conservative, the 2021 decreases in cancer screening are expected to be much greater and are likely to increase cancer disparities substantially.
登录
查看更多内容
影响因子：
29.4
作者：
National Cancer Institute’s PROSPR Consortium;Corley DA;Sedki M;Ritzwoller DP;Greenlee RT;Neslund-Dudas C;Rendle KA;Honda SA;Schottinger JE;Udaltsova N;Vachani A;Kobrin S;Li CI;Haas JS
通讯作者：
Haas JS
评估在Covid-19大流行期间接受肺癌治疗和监测的患者的困扰水平。
DOI：
10.1016/j.nurpra.2020.10.020
发表时间：
2021-04
期刊：
The journal for nurse practitioners : JNP
影响因子：
--
作者：
Albano D;Feraca M;Nemesure B
通讯作者：
Nemesure B
影响因子：
3.8
作者：
Brivio E;Guiddi P;Scotto L;Giudice AV;Pettini G;Busacchio D;Didier F;Mazzocco K;Pravettoni G
通讯作者：
Pravettoni G
影响因子：
28.4
作者：
Ko, Naomi Y.;Hong, Susan;Calip, Gregory S.
通讯作者：
Calip, Gregory S.
影响因子：
4
作者：
Li, Lihua;Ji, Jiayi;Liu, Bian
通讯作者：
Liu, Bian